NASDAQ
CBIO

Catalyst Biosciences Inc

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Catalyst Biosciences Inc Stock Price

Vitals

Today's Low:
$0.5400
Today's High:
$0.5765
Open Price:
$0.5600
52W Low:
$0.35
52W High:
$3.249
Prev. Close:
$0.5581
Volume:
103082

Company Statistics

Market Cap.:
$0.018 billion
Book Value:
2.512
Revenue TTM:
$0.006 billion
Operating Margin TTM:
-1099%
Gross Profit TTM:
$-0.065 billion
Gross Profit TTM:
$-0.065 billion
Profit Margin:
-153.1%
Return on Assets TTM:
-41%
Return on Equity TTM:
-10.3%

Company Profile

Catalyst Biosciences Inc had its IPO on 2006-04-12 under the ticker symbol CBIO.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Catalyst Biosciences Inc has a staff strength of 0 employees.

Stock update

Shares of Catalyst Biosciences Inc opened at $0.56 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $0.54 - $0.58, and closed at $0.56.

This is a -0.38% slip from the previous day's closing price.

A total volume of 103,082 shares were traded at the close of the day’s session.

In the last one week, shares of Catalyst Biosciences Inc have slipped by -44.4%.

Catalyst Biosciences Inc's Key Ratios

Catalyst Biosciences Inc has a market cap of $0.018 billion, indicating a price to book ratio of 0.231 and a price to sales ratio of 3.186.

In the last 12-months Catalyst Biosciences Inc’s revenue was $0.006 billion with a gross profit of $-0.065 billion and an EBITDA of $-0.060 billion. The EBITDA ratio measures Catalyst Biosciences Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Catalyst Biosciences Inc’s operating margin was -1099% while its return on assets stood at -41% with a return of equity of -10.3%.

In Q2, Catalyst Biosciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 45.9%.

Catalyst Biosciences Inc’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
0.02

Its diluted EPS in the last 12-months stands at $-2.548 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0.02. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Catalyst Biosciences Inc’s profitability.

Catalyst Biosciences Inc stock is trading at a EV to sales ratio of 4.975 and a EV to EBITDA ratio of 0.849. Its price to sales ratio in the trailing 12-months stood at 3.186.

Catalyst Biosciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Catalyst Biosciences Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Catalyst Biosciences Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Catalyst Biosciences Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Catalyst Biosciences Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Catalyst Biosciences Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$0.56
52-Week High
$3.249
52-Week Low
$0.35
Analyst Target Price
$16

Catalyst Biosciences Inc stock is currently trading at $0.56 per share. It touched a 52-week high of $3.249 and a 52-week low of $3.249. Analysts tracking the stock have a 12-month average target price of $16.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Catalyst Biosciences Inc

The stock symbol (also called stock or share ticker) of Catalyst Biosciences Inc is CBIO

The IPO of Catalyst Biosciences Inc took place on 2006-04-12

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
$16.93
-0.57
-3.26%
$1.62
-0.03
-1.82%
$0.53
-0
-0.36%
$2.53
-0.07
-2.69%
$13.53
-0.45
-3.22%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, is focused on developing candidates for protease products in the fields of hemostasis and complement regulation. The company is headquartered in South San Francisco, California.

Address

611 GATEWAY BLVD., SUITE 710, SOUTH SAN FRANCISCO, CA, US